BIAF Earnings

Quarterly EPS
$-90.17
Q4 2024
$-2.40
Q1 2025
$-76.05
Q2 2025
$-71.05
Q3 2025
$0.00
Q4 2025
$-12.15
Q1 2026
$-9.60
Q2 2026
$-5.89
Q3 2026
Latest Revenue1.1M
Latest Net Income-5277023
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$5.891.1M-5277023-26.0%+91.7%
Q2 2026-$9.601.5M-3366082+19.0%+87.4%
Q1 2026-$12.151.4M-3630610-27.1%-406.3%
Q4 2025—1.6M-3137466-27.8%—
Q3 2025-$71.051.4M-5051084-38.5%+2.1%
Q2 2025-$76.051.3M-4060787-47.1%+11.1%
Q1 2025-$2.401.9M-2660417-23.0%+97.3%
Q4 2024-$90.172.2M-2966897-0.3%+21.1%
Q3 2024-$72.602.4M-2000840——
Q2 2024-$85.502.4M-2110279——
Q1 2024-$90.002.4M-1961815——
Q4 2023-$114.352.2M-2373164——
bioAffinity Technologies (BIAF) — Earnings